Premium
Acne conglobata responding to buserelin, a gonadotrophin‐releasing hormone analogue
Author(s) -
WAXMAN J.,
RUSTIN M.H.A.,
PERRY L.,
KIRBY J.D.T.
Publication year - 1983
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1983.tb00550.x
Subject(s) - buserelin , acne , medicine , hormone , endocrinology , oncology , dermatology , receptor , agonist
SUMMARY A 65‐year‐old man who had had acne conglabata since early adult life was treated with buserelin for advanced prostatic cancer. Within i month of starting therapy, the inflammatory acne had completely resolved and this coincided with remission of the carcinoma. Gonadotrophin‐releasing hormone analogues may be useful in the treatment of resistant acne.